INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M
Data sources
SEC Form 457m ago
House PTR57m ago
SEC 13F57m ago
Robinhood Chain57m ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
34
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$75K
3,402 sh
Aug 5, 2026Aug 13, 2026
Page 511 of 1693
← PrevNext →
traded Aug 5, 2026
+8d
SEC Form 4

Evidence

33
DB
Durso Jerome BenedictDirector, President and CEO
ALTAltimmune, Inc.
Open-market purchase
BUY$44K
15.0K sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC Form 4

Evidence

32
YM
Young Kenneth MDirector, Chief Executive Officer
BWBabcock & Wilcox Enterprises, Inc.
Open-market purchase
BUY$68K
7,000 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.63M
9,934 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
GL
Gruber David LDirector
LTCLTC PROPERTIES INC
Open-market purchase
BUY$134K
3,500 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
NA
Nanduru AnilSenior Vice President
GGenpact LTD
Open-market sale
SELL$402K
11.9K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.52M
28.7K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.62M
62.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
TA
Tezel AhmetChief Innovation Officer
LIVNLivaNova PLC
Open-market sale
SELL$208K
2,675 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

31
KJ
Kuai JeffGeneral Manager, Pizza Hut
YUMCYum China Holdings, Inc.
Open-market sale
SELL$253K
5,313 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$2,199
100 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$9,776
447 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,410
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Open-market sale
SELL$653K
5,000 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$23K
1,040 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$26K
1,180 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$17K
753 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$6,252
300 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$10K
480 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,410
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$26K
1,163 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$22K
988 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$8,808
400 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$15K
672 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$34K
1,556 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$2,211
100 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$15K
700 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,420
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$29K
1,332 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
CE
Childers Jason E.SVP, Information Technology
WRLDWORLD ACCEPTANCE CORP
Open-market sale
SELL$381K
2,000 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$9,649
443 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

30
LC
Lightheart CharmaineEVP/CRDEO
RVSBRIVERVIEW BANCORP INC
Open-market purchase
BUY$1,327
250 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

30
AT
Archer Edward T.EVP, Sales & Marketing
FNFabrinet
Tax withholding
F$1.72M
3,263 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

29
MM
Mink Brook Asset Management LLC10% Owner
DLHCDLH Holdings Corp.
Open-market purchase
BUY$2,356
500 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$284K
3,120 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

29
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$605K
3,704 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

29
LG
Lucas Stephen GSVP, Culture and Engagement
KOPKoppers Holdings Inc.
Open-market sale
SELL$58K
1,308 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

28
BL
Byers Deborah LDirector
KNTKKinetik Holdings Inc.
Open-market sale
SELL$141K
2,739 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

28
AA
Ahmed AsmauDirector
QNSTQUINSTREET, INC
Open-market sale
SELL$104K
5,000 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

28
KJ
Kuai JeffGeneral Manager, Pizza Hut
YUMCYum China Holdings, Inc.
Open-market sale
SELL$206K
4,312 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence